Research

C-TRACT Trial

C-TRACT(Chronic Venous Thrombosis: Relief with Adjunctive Catheter-Directed Therapy) is a multicenter, randomized trial led by Suresh Vedantham, MD, FSIR, of the Mallinckrodt Institute of Radiology, Washington University in St. Louis.

PRESERVE Trial

PRESERVE is the first large-scale, multi-specialty prospective clinical research trial to evaluate IVC filters use and long term follow-up.

ATTRACT trial

ATTRACT was designed to evaluate the ability of pharmacomechanical catheter-directed thrombolysis (PCDT) to reduce the incidence and severity in patients with acute proximal deep vein thrombosis (DVT).

EMBOLIZE trial

The EMBOLIZE trial is a first-of-its-kind prospective, randomized controlled trial studying the effects of ovarian vein embolization (OVE) in reducing pain in women experiencing chronic pain due to pelvic venous disease (PeVD).

Women's Research Mentorship Grant

Supports women performing IR research and to expand the pipeline for medical students or residents to learn about IR research.

Pilot Research Grant

Funds research in areas that advance IR and patient care. These grants generally address a specific hypothesis and generate preliminary data to strengthen applications to peer-reviewed funding agencies. For faculty and those with limited research experience.

Academic Transition Grant

Facilitates independent research and academic success, this grant is for interventional radiologists over the age of 40 who’ve recently begun academic careers after years in non-academic practice.

Allied Scientist Grant

Provides support for trainees enrolled in graduate-level training programs outside the clinical realm of IR but still crucial to IR’s future. Goal: create collaborative research training environments.

Dr. and Mrs. W. C. Culp Student Research Grant

Designed to foster an interest in research by funding a summer research project conducted by a medical student in an area identified by SIR Foundation as important to the advancement of interventional radiology and patient care.

Dr. Ernest J. Ring Academic Development Grant

Supports junior IR faculty members early in their academic careers to allow time for research. The goal is for grant recipients to subsequently obtain additional funding from other sources, such as NIH.

TARE the Hazards: Bringing High-Risk Patients to the Transplant Finish Line

It is a difficult truth that many patients diagnosed with hepatocellular carcinoma (HCC) must simultaneously confront the perils of underlying chronic liver disease, a threat to survival that often surpasses malignancy itself. Furthermore, the cirrhotic liver’s inherent predisposition to HCC makes preservation of hepatic substrate as paramount as cancer care.

Transarterial Embolization for Refractory Adhesive Capsulitis and Related Tendinopathies: A Systematic Review and Meta-Analysis

This study aimed to synthesize evidence on transarterial embolization (TAE) for adhesive capsulitis and related shoulder tendinopathies to quantify pooled changes in pain, range of motion (ROM), American Shoulder and Elbow Surgeons (ASES) scores, and safety outcomes

Embolization for Hemoptysis in Pulmonary Aspergillosis: Effectiveness and Risk Factors for Recurrence

To evaluate the characteristics and effectiveness of embolization for hemoptysis due to pulmonary aspergillosis and analyze the risk factors for recurrence.

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Combined with Model for End-Stage Liver Disease 3.0 as a Prognostic Predictor for Patients with Liver Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Creation

To evaluate the prognostic value of combining neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with Model for End-stage Liver Disease (MELD)–based scores in predicting mortality after transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with cirrhosis.

Standardized Technique for Prostatic Artery Embolization: A Delphi Consensus Study on Optimized Methods and Emerging Concepts

Prostatic artery embolization (PAE) is a safe and effective treatment for management of lower urinary tract symptoms in men with benign prostatic hyperplasia. Despite its clinical effectiveness, PAE remains technically demanding, necessitating standardized procedural steps to optimize outcomes.

Glue (n-Butyl Cyanoacrylate) for Prostate Artery Embolization: Development of a Glue Penetration Score and Association with Clinical Outcomes

To develop a simple imaging-based scoring system, the prostate artery embolization (PAE)–glue penetration score (GPS; 0–6), for use in PAE with n-butyl cyanoacrylate (nBCA) and to examine how it relates to patient outcomes.In a single-institution retrospective cohort of 49 men (July 2021 to May 2023), 2 blinded readers graded glue penetration per hemigland (0–3) and summed scores to a total PAE-GPS (0–6).